These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2965970)
1. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study. Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970 [TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo. Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239 [TBL] [Abstract][Full Text] [Related]
3. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer. Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of iododeoxyuridine into DNA of granulocytes in patients. Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659 [TBL] [Abstract][Full Text] [Related]
6. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts. Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259 [TBL] [Abstract][Full Text] [Related]
7. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis. Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893 [TBL] [Abstract][Full Text] [Related]
8. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies. Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075 [TBL] [Abstract][Full Text] [Related]
9. Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine. Coucke PA; Cottin E; Azria D; Martineau P; Adamer F; Decosterd LA; Buchegger F; Do HP Eur J Cancer; 2004 Jul; 40(10):1572-80. PubMed ID: 15196542 [TBL] [Abstract][Full Text] [Related]
10. Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines. Benson AB; Trump DL; Cummings KB; Fischer PH Biochem Pharmacol; 1985 Nov; 34(21):3925-31. PubMed ID: 2933042 [TBL] [Abstract][Full Text] [Related]
11. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts. Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880 [TBL] [Abstract][Full Text] [Related]
12. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642 [TBL] [Abstract][Full Text] [Related]
13. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine. Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821 [TBL] [Abstract][Full Text] [Related]
14. Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine. Buchegger F; Vieira JM; Blaeuenstein P; Dupertuis YM; Schaffland AO; Grannavel C; de Tribolet N; Slosman DO; Bischof Delaloye A Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):239-46. PubMed ID: 12552342 [TBL] [Abstract][Full Text] [Related]
15. Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine. Perillo-Adamer F; Delaloye AB; Genton CS; Schaffland AO; Dupertuis YM; Buchegger F Eur J Nucl Med Mol Imaging; 2006 May; 33(5):613-20. PubMed ID: 16450135 [TBL] [Abstract][Full Text] [Related]
16. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation. Greene RF; Collins JM Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128 [TBL] [Abstract][Full Text] [Related]
17. ICI D1694 and idoxuridine: a synergistic antitumor combination. Pressacco J; Hedley DW; Erlichman C Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097 [TBL] [Abstract][Full Text] [Related]
18. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits. Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238 [TBL] [Abstract][Full Text] [Related]
19. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059 [TBL] [Abstract][Full Text] [Related]
20. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells. Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]